| Upcoming events on ENANTA PHARMACEUTICALS, INC. |
|
| 02/10/21 | | Q1 2021 Earnings Release (Projected) |
| 03/02/21 | | Annual General Meeting |
| 05/10/21 | | Interim 2021 Earnings Release (Projected) |
| 08/10/21 | | Q3 2021 Earnings Release (Projected) |
|
| Past events on ENANTA PHARMACEUTICALS, INC. |
|
| 01/12/21 | 08:20am | | JP Morgan Healthcare Conference |
| 12/02/20 | | Piper Sandler Health Care Conference |
| 12/01/20 | 09:15am | | Evercore ISI HealthCONx Conference |
| 11/23/20 | 04:30pm | | FY 2020 Earnings Call |
|
| Upcoming sector events for ENANTA PHARMACEUTICALS, INC. |
|
|
| |
|
| Past sector events for ENANTA PHARMACEUTICALS, INC. |
|
|
|
|
|
| Annual results | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 (e) |
Sales
M $ |
Released
Forecast
Spread | 88,3
88,8
-0,58% | 103
101
2,0% | 207
208
-0,87% | 205
210
-2,2% | 122
125
-1,7% |
99,2
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread |
| 26,8
| 90,8
| 59,2
46,0
29% | -18,4
-44,0
58% |
-107
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 30,8
31,4
-1,7% | 24,6
22,7
8,5% | 88,3
85,1
3,7% | 36,7
42,0
-12% | -41,6
-43,9
5,2% |
-91,3
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 32,6
32,7
-0,51% | 26,9
24,2
11% | 93,1
90,2
3,2% | 45,6
51,2
-11% | -35,0
-37,3
6,1% |
-89,7
|
Net income
M $ |
Released
Forecast
Spread | 21,7
21,4
1,1% | 17,7
18,4
-3,8% | 72,0
69,9
2,9% | 46,4
49,6
-6,6% | -36,2
-25,4
-42% |
-86,2
|
EPS
$ |
Released
Forecast
Spread | 1,13
1,08
4,6% | 0,91
0,92
-1,0% | 3,48
3,38
2,9% | 2,21
2,35
-6,0% | -1,81
-1,29
-40% |
-4,14
| | Announcement Date | 11/21/2016 | 11/20/2017 | 11/26/2018 | 11/21/2019 | 11/23/2020 | |
|
|
|
| Quarterly results | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) | 2022 Q1 (e) |
Sales
M $ |
Released
Forecast
Spread | 57,3
56,9
0,65% | 67,2
69,0
-2,6% | 69,9
71,3
-1,9% | 39,6
40,9
-3,2% | 44,4
47,0
-5,6% | 51,3
55,9
-8,3% | 52,6
58,7
-11% | 27,6
29,2
-5,3% | 18,7
25,5
-27% | 23,6
25,8
-8,2% |
27,2
|
21,5
|
22,1
|
26,8
|
34,8
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread |
|
| 28,5
31,1
-8,2% | -0,50
-2,80
82% | 4,64
12,5
-63% | 11,8
19,0
-38% | 13,8
12,3
12% | -11,0
-15,8
31% |
|
|
|
|
|
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 22,6
26,7
-15% | 34,5
31,3
10% | 27,9
35,0
-20% | -1,30
-1,30
-0,35% | 3,76
3,14
20% | 6,43
11,7
-45% | 12,9
12,4
4,0% | -11,9
-17,8
33% | -22,9
-22,7
-0,85% | -19,8
-22,0
10% |
-18,4
|
-25,3
|
-26,2
|
-23,3
|
-11,7
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 24,0
26,1
-8,2% | 35,9
32,8
9,5% | 29,7
37,1
-20% | 0,94
-2,16
144% | 6,17
1,78
247% | 8,71
14,4
-39% | 14,9
14,2
5,5% | -9,93
-16,3
39% | -21,4
-22,0
2,7% | -18,6
-20,8
10% |
-18,4
|
-25,1
|
-25,9
|
-24,6
|
-10,3
|
Net income
M $ |
Released
Forecast
Spread | 20,3
19,9
1,8% | 27,4
25,7
6,6% | 26,0
29,2
-11% | 4,15
-3,09
234% | 7,04
3,20
120% | 9,19
12,3
-25% | 13,4
11,8
14% | -6,01
-16,3
63% | -14,3
-20,8
32% | -29,3
-18,5
-58% |
-17,2
|
-23,9
|
-24,5
|
-23,0
|
-10,6
|
EPS
$ |
Released
Forecast
Spread | 0,97
0,94
3,3% | 1,30
1,22
6,5% | 1,25
1,39
-10,0% | 0,20
-0,09
319% | 0,33
0,14
133% | 0,44
0,56
-21% | 0,65
0,56
15% | -0,30
-0,73
59% | -0,71
-0,97
26% | -1,46
-0,94
-55% |
-0,83
|
-1,14
|
-1,18
|
-1,07
|
-0,49
| | Announcement Date | 08/07/2018 | 11/26/2018 | 02/06/2019 | 05/07/2019 | 08/06/2019 | 11/21/2019 | 02/06/2020 | 05/06/2020 | 08/04/2020 | 11/23/2020 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
